Jun 28, 2026
Jun 28, 2026
Jun 28, 2026
Jun 28, 2026
Jun 28, 2026
Jun 28, 2026
Jun 28, 2026
Jun 28, 2026
about 12 hours ago
Orbimed Advisors recently sold 860,123 shares of Enliven Therapeutics, valued at $39 million. This move raises questions about future strategies and the potential impact on the crypto markets.
about 12 hours ago
Oruka Therapeutics' executive Arjun Agarwal offloaded $687K in shares. What does this insider move signal for investors amid a 700% stock surge?
about 12 hours ago
Hyperliquid finds itself in hot water as Singapore's financial regulator places it on the Investor Alert List. The platform's claims of being permissionless face scrutiny, with critics pointing to governance issues.